Role of the Activation Gate in Determining the Extracellular Potassium Dependency of Block of HERG by Trapped Drugs  by Pareja, Kristeen et al.
428a Tuesday, March 8, 2011KCNQ2 but not KNCQ3, is expressed on neuronal axons, where it might reg-
ulate action potential propagation or neurotransmitter release.
Previously, we showed that Syntaxin 1A physically interacts with homomeric
KCNQ2 in brain synaptosomes and in Xenopus oocytes. In oocytes, this inter-
action results in a reduction of the current’s amplitude and reduction of the
channel’s activation rate. In vitro pull down revealed that Syntaxin 1A specif-
ically binds the Helix A domain located in the C-terminus of both KCNQ2 and
KCNQ3. However, binding of Syntaxin to Helix A does not mediate Syntaxin’s
effect on the channel. We propose that the N-trminus of KCNQ2 plays a major
role in the syntaxin’s modulation since substitution of the proximal N-terminus
of KCNQ2 with that of KCNQ3 abolished this effect.
Since the effect of syntaxin 1A is mediated through the N-terminus we assume
that the N-C termini of the channel interact. To study this hypothesis we used
florescence resonance energy transfer (FRET) experiments, single channel
analysis and biochemical approaches using chimeric channels.
Together, our results point toward an allosteric modulation of KCNQ2 gating
by Syntaxin 1A, facilitated by N-C termini interaction.
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Slowing of Instantaneous Inactivation Causes Macroscopic Current Decay
in Kv7.1 Alanine Mutants
Vitya Vardanyan, Lijuan Ma, Olaf Pongs.
Alanine scanningmutagenesis inKv7.1 S4-S5 linker and the pore region revealed
mutant channels with fast current decay at permanent depolarizing pulses above
10mV. It has beenpreviously shown that such amacroscopic inactivation ofmany
Kv7.1 poremutantsoccurs inparallel to instantaneous inactivationofKv7.1chan-
nel. We have chosen four mutant channels I268A, G269A, F339A and F340A
withmost pronounced current decays to investigate themolecularmechanismun-
derling decay process. Inactivation of these channels could not be explained by
intracellularNaþ block reported earlier forKv7.1wild type channel. The fast cur-
rent decay kinetics significantly changed neither by varying the extracellular Kþ
concentration nor by replacement of theKþwith equimolar Rbþ. Recovery from
inactivation showed fast and slow components. The slow component was accel-
erated at high extracellular Kþ conditions, whereas the fast component did not
change significantly. Our data suggest that instantaneous inactivation of wild
type Kv7.1 channel markedly slowed by above mentioned alanine mutations re-
sulting in macroscopic decay of current during prolonged depolarization.
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Dynamic Modulation of Voltage-Dependent Kv7.2-7.3 Channel Opening
by Voltage-Sensor Relaxation
Carlos A. Villalba-Galea, Junghoon Ha, I. Scott Ramsey.
S4-type voltage-sensor (VS) domains are common to voltage-gated ion channels
(VGCs) and voltage-sensitive phosphatases (VSPs). In ciVSP, depolarization to
þ80 mV initially causes VS activation, generating rapid sensing charge (Q)
movement. Sustained depolarization subsequently elicits a voltage-
independent conformational rearrangement termed relaxation. Because the re-
laxed state is thermodynamically more stable than the activated state, relaxation
causes a negative shift in the Q-V relation. Relaxation may be an intrinsic prop-
erty of theVS domain because it is observed in the absence of the ciVSP catalytic
domain. Since the VS and pore domains are coupled in VGCs, we wondered
whether VS relaxation might alter voltage-dependent opening of an ion channel
conductance (G). By analogy to ciVSP, we hypothesized that relaxation would
shift the G-V relation toward negative potentials. In order to test this hypothesis,
weused two-electrodevoltageclamp tomeasureKþ currents inXenopusoocytes
expressing Kv7.2 and Kv7.3mRNAs. As expected, prolonged depolarizations to
þ80mV caused the steady-state G-V relation to shift toward negative potentials,
indicating thatVS relaxation alters the voltage-dependence of channel opening in
heteromeric Kv7.2-7.3 channels. Furthermore, the magnitude of the shift in the
midpoint of the G-V relation was found to depend on the duration of the þ80
mV prepulse. Similar to ciVSP, the progressive shift in the G-V relation may
be interpreted as an index of relaxation and used to measure the rates of entry
into and recovery from the relaxed state. Our data therefore imply that the voltage
dependence ofVGCopening is likely to be dynamicallymodulated by conforma-
tional transitions that are intrinsic to the VS domain in a voltage-gated channel
complex. VS relaxation may represent a widespread mechanism for regulating
VGC function altering the relative positions of the Q-V and G-V relations.
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KCNQ1-R539WMutationSubstitutesCholesterol forPhosphatidylinositol-
4, 5-Bisphosphate in Channel Regulation
Julien Piron, Mohamed Yassine Amarouch, Je´roˆme Mordel,
Ce´line S. Nicolas, Annick Thomas, Robert Brasseur, Flavien Charpentier,
Jean Me´rot, Isabelle Baro´, Gildas Loussouarn.
Point mutation of nearby residues in ion channels can be associated with dia-
metrically opposed clinical phenotypes despite the mutant channels exhibitsimilar biophysical characteristics. Hence a characterization of the channel
structure/function at the amino-acid scale is required for better understanding
of channel genotype/phenotype relationship. R555C and R539W KCNQ1 mu-
tant channels are a good illustration of this idea: R555C mutation is associated
with a fruste form of type 1 long QT syndrome, whereas R539W mutation is
associated with sudden death. Puzzling enough, the genotype/phenotype rela-
tionship is difficult to understand because the mutated residues are in the
same helix C module, they both concern arginine residues, both channels
have the same biophysical properties, and the same sensitivity to short chain
phosphatidylinositol-4,5-bisphosphate (PIP2).
To better understand the genotype/phenotype relationship in the context of
these mutations, we performed several tests in COS-7 cells expressing the
WT or mutant channels and used tail-currents amplitudes as readout. We
show that R539W is very peculiar: As opposed to WT and R555C channels,
the R539W channel current is barely running down when available PIP2 is de-
creased, either by wortmannin application in whole-cell, or by magnesium ap-
plication in inside-out configuration. Consistent with that, the R539W channel
is also insensitive to extracellular osmolarity, known to modulate the channel
activity via PIP2. These results suggest that KCNQ1-R539W mutation short-
cuts PIP2 in the channel open pore stabilization. Both structural model predic-
tion and functional analysis implicate membrane cholesterol in this effect.
Indeed, structural model prediction suggests that the introduced tryptophan
in R539W interacts with cholesterol. Both cyclodextrin application on
R539W and substitution of R539 by residues other than tryptophan restore
channel rundown, consistent with the supposed tryptophan-cholesterol interac-
tion. We conclude that the R539W/cholesterol interaction substitutes for R539/
PIP2 interaction in the channel open pore stabilization.
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N-Glycans Modulate hERG1A Window Current
Sarah A. Norring, Tara A. Schwetz, Andrew R. Ednie, Eric S. Bennett.
Voltage-gated Kþ channels are primarily responsible for the repolarization
phases of neuronal, skeletal and cardiac muscle action potentials. Activity of
the human ether-a-go-go-related gene 1 (hERG1) voltage-gated Kþ channel
produces a Kþ current responsible for much of late phase II and phase III re-
polarization of the human cardiac action potential. HERG1A has two putative
N-glycosylation sites located in the S5-S6 linker region, one of which is N-gly-
cosylated. The aim of this study was to determine whether and how N-linked
glycosylation modifies hERG1A channel function. Voltage-dependent gating
of hERG1A were evaluated under conditions of full glycosylation, no sialyla-
tion, in the absence of complex N-glycans, and following the removal of the full
N-glycosylation structure. The hERG1A steady-state activation relationships
were shifted along the voltage axis by a significant, depolarizing ~9 mV under
each condition of reduced glycosylation. Steady state channel availability
curves were shifted by a much greater depolarizing 20-30 mV under conditions
of reduced glycosylation. The depolarizing, non-uniform shifts in voltage-
dependent steady state activation and inactivation caused a large rightward shift
and an increase in the hERG1A window current. This suggests that reduced
glycosylation caused an increase in the persistent hERG current that occurs
at more depolarized potentials as observed. This increase and shift in window
current would lead to increased hERG1A activity during the action potential,
effectively increasing the rate of repolarization, and reducing AP duration, as
predicted through in silico modeling of the ventricular AP. Overall, these
data indicate a functional role for N-glycosylation in the modulation of
hERG1A channel activity, suggesting that even small changes in channel N-
glycosylation modulate hERG1A activity, and thereby likely impact the rate
of action potential repolarization.
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Role of the Activation Gate in Determining the Extracellular Potassium
Dependency of Block of HERG by Trapped Drugs
Kristeen Pareja, Barbara Olkiewicz, Kristopher Murphy, August Anderson,
Alan Miller.
Block of the cardiac potassium channel HERG by a number of drugs has been
shown to decrease with an increase in the extracellular potassium concentra-
tion. This dependency on extracellular potassium can be explained by at least
two mechanisms: 1) destabilization of the drug by the permeant ion 2) differ-
ential binding to the inactivated state. We have previously shown that block
of HERG by quinidine, a drug that is not trapped after channel deactivation,
correlates better with the permeant ion than with inactivation, indicating that
quinidine block is destabilized by the permeant ion.1 We show here that block
of HERG by terfenadine and bepridil, drugs shown to be trapped in the channel
after channel deactivation2, is not altered with an increase in the extracellular
potassium concentration. Furthermore block by both terfenadine and bepridil
of the HERG mutant D540K, which opens with both depolarization and
Tuesday, March 8, 2011 429ahyperpolarization, is decreased with increased extracellular potassium, similar
to the effect of extracellular potassium on block of WT HERG by quinidine. In
addition, block of D540K by bepridil at120 mV, a voltage at which D540K is
open and does not inactivate is similar in 0 mM extracellular K and 20 mM
NH4 and reduced in 20 mM extracellular K and 20 mM extracellular Cs. Given
that the permeability sequence through HERG is PK>PCs>PNH4, these results
suggest that the permeant ion is not able to destabilize a trapped drug but is able
to destabilize a drug that is not trapped and suggest a possible role for the ac-
tivation gate in determining the extracellular potassium dependency of block of
HERG by certain compounds.
1 Barrows et al. (2009) Channels: 3(4) :239 248.
2 Stork et al. (2007) BJP151:1368-1376.
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Identification and Biophysical Characterization of a Compound that
Protects HERG from Block by a Proarrhythmic Agent
Franck Potet, Chaigne Sebastien, Hopkins Corey, Lewis Michelle,
Engers Darren, Zhou Beiyan, Balser R. Jeffrey, Li Min, Lindsley Craig,
Weaver David, Kupershmidt Sabina.
Ion channel modulation is a major target for cardiovascular therapeutics. The
hERG-encoded Kþ current, IKr is essential for cardiac repolarization but also
a source of cardiotoxicity. Unintended hERG inhibition by diverse pharmaceu-
ticals can cause sudden cardiac death. We used a high-throughput assay to test
the hypothesis that IKr reduction in response to an inhibitor, dofetilide, could be
prevented by a small molecule. We screened more than 300,000 compounds for
agents that increase the IC70 of dofetilide.
One compound (VU0405601), with the desired activity was further character-
ized: On its own, VU0405601 enhances hERG test-pulse (10 mV) and tail cur-
rent (50 mV) 5.3 and 2.5 fold, respectively, with an EC50 around 22 mM.
VU0405601 shifted the half-maximal voltage-dependence (V1/2) of activation
by14mV. The activation time course was accelerated (899.7 vs 258.2 ms); ki-
netics of deactivation were slowed. The V1/2 of inactivation was shifted byþ16
mV. Rate of inactivation and recovery from inactivation were slowed and has-
tened, respectively. Studieswith the inactivation-removed hERG-S631Avariant
showed a greatly reducedVU0405601 effect on the test-pulse current, indicating
that reduced inactivation is the primary mechanism. Competition studies with
the hERG toxin BeKm-1 (binds the outer vestibule) and dofetilide (an inner cav-
ity blocker), revealed that BeKm-1 but not dofetilide suppressedVU0405601 ac-
tivator effects. Hence, VU0405601 impacts the outer vestibule.
Dofetilide block of IKr develops gradually, with continuous pulsing. After 15
minutes of pulsing, 89% of the current is inhibited with 100 nM dofetilide alone
but in the presence of VU0405601, 49% of the current remains, indicating that
VU0405601 protects hERG from inhibition. Development of a small molecule
that decreases the risk of arrhythmias in response to hERG inhibitors would im-
prove public health and facilitate drug discovery.
2322-Pos Board B308
Molecular Determinants of HERG Potassium Channel Inhibition by Diso-
pyramide
Aziza El Harchi, Christopher E. Dempsey, Jules C. Hancox.
The class Ia antiarrhythmic drug disopyramide (DISO) delays cardiac ventric-
ular repolarization through inhibition of the hERG-encoded, pore-forming sub-
unit of the rapid delayed rectifier Kþ current (IKr). In contrast with high-affinity
hERG blockers DISO’s inhibitory action on hERG is less dependent upon chan-
nel inactivation, raising the possibility that DISO binding to hERGmay in some
way be distinct [1,2]. Here the sensitivity to DISO of mutants of two aromatic
residues (Y652A and F656A) in the S6 domain was investigated. Whole-cell
patch clamp recordings were made at 37oC from HEK-293 cells stably express-
ing WT hERG or hERG mutants Y652A or F656A. WT hERG current (IhERG)
tails at 40 mV following depolarization to þ20 mV were inhibited with an
IC50 of 7.25 0.06 mM. The Y652A mutation greatly attenuated DISO inhibi-
tion of IhERG tail (IC50=402 5 0.04 mM) and also abolished voltage-
dependence of inhibition that was present for WT IhERG. F656A IhERG tails at
120 mV (recorded with a high [Kþ]e of 94 mM to facilitate current measure-
ment) yielded a very high IC50of 1.8550.07 mM. Preliminary docking anal-
ysis using a homology model built onto the KvAP crystal structure template
suggests that in low-energy binding configurations the aromatic groups of
DISO may reside at the lower end of the pore cavity. Collectively, these find-
ings suggest a critical role for canonical binding residues Y652 and F656 in
DISO inhibition of hERG and implicate Y652 in the voltage-dependence of
hERG inhibition by DISO.
This work was supported by the British Heart Foundation.
1. Paul AA et al (2001) BBRC, 280; 1243-50
2. McPate MJ et al (2008) Br J Pharmacol, 155, 957-662323-Pos Board B309
Molecular Composition of Functional KCNQ Channels in Vascular
Smooth Muscle Cells Based on Effects of Diclofenac
Lyubov I. Brueggemann, Kenneth L. Byron.
KCNQ4 and KCNQ5 potassium channel subunits are expressed in vascular
smooth muscle cells, though it remains uncertain how these subunits assemble
to form functional channels. Using patch-clamp techniques, we compared the
electrophysiological characteristics and effects of diclofenac, a known KCNQ
channel activator, on human KCNQ4 and KCNQ5 channels expressed indi-
vidually or together in A7r5 rat aortic smooth muscle cells. The conductance
curves of the overexpressed channels were fit by a single Boltzmann function
in each case (V0.5 values: 31 mV, 44 mV, and 38 mV for KCNQ4,
KCNQ5, and KCNQ4/5, respectively). Diclofenac (100 mM) increased maxi-
mum conductance of KCNQ4 channels by 38%, but inhibited KCNQ5 and
KCNQ4/5 channels, reducing maximum conductance by 53% and by 32% re-
spectively. Differences in deactivation rates and distinct voltage-dependent ef-
fects of diclofenac on channel activation and deactivation observed with each
of the subunit combinations (KCNQ4, KCNQ5 and KCNQ4/5) were used as
diagnostic tools to evaluate native KCNQ currents in vascular smooth muscle
cells. A7r5 cells express only KCNQ5 channels endogenously and their re-
sponses to diclofenac closely resembled those of the overexpressed KCNQ5
currents. In contrast, mesenteric artery myocytes, which express both
KCNQ4 and KCNQ5 channels, displayed whole-cell KCNQ currents with
properties and diclofenac responses characteristic of overexpressed hetero-
meric KCNQ4/5 channels.2324-Pos Board B310
Celecoxib Blocks Cardiac Kv1.5, Kv4.3 and Kv7.1 (KCNQ1) Channels.
Effects on Cardiac Action Potentials
Alvaro Macias, Cristina Moreno, Javier Moral-Sanz, Angel Cogolludo,
Miren David, Matteo Alemanni, Francisco Perez-Vizcaino, Antonio Zaza,
Carmen Valenzuela, Teresa Gonzalez.
Celecoxib is a COX-2 inhibitor that has been related to an increased car-
diovascular risk and that exerts several actions on different targets. The
aim of this study was to analyze the effects of this drug on human cardiac
voltage-gated potassium channels (Kv) involved on cardiac repolarization
Kv1.5 (IKur), Kv4.3þKChIP2 (Ito1) and Kv7.1þKCNE1 (IKs) and to com-
pare with another COX-2 inhibitor, rofecoxib. Currents were recorded in
transfected mammalian cells by whole-cell patch-clamp. Celecoxib blocked
all the Kv channels analyzed and rofecoxib was always less potent, except
on Kv4.3þKChIP2 channels. Kv1.5 block increased in the voltage range
of channel activation, decreasing at potentials positive to 0 mV. The
drug modified the activation curve of the channels that became biphasic.
Block was frequency-dependent, increasing at fastest frequencies. Cele-
coxib effects were not altered by TEAout in R487Y mutant Kv1.5 channels
but the kinetics of block were slower and the degree of block smaller with
TEAin, indicating that celecoxib acts from the cytosolic side. We con-
firmed the blocking properties of celecoxib on native Kv currents from
rat vascular cells, where Kv1.5 are the main contributors (IC50z7 mM).
Finally, we demonstrate that celecoxib prolongs the action potential dura-
tion in mouse cardiac myocytes and shortens it in guinea pig cardiac my-
ocytes; suggesting that Kv block induced by celecoxib may be of clinical
relevance. Supported by SAF2007-65868, SAF2008-03948, SAF2010-
14916, AGL2007-66108, RECAVA RD06/0014/0006 and Fundacio´n Mutua
Madrilen˜a.2325-Pos Board B311
Celecoxib Promotes a Fast Inactivation Gating in Shab Kþ Channels
Imilla I. Arias-Olguı´n, Elisa Carrillo, Bernardo Meza, Daniel Balleza,
Froylan Gomez-Lagunas.
Celecoxib selectively inhibits COX-2, an inflammation-inducible cyclooxyge-
nase isoform. Recently it has been described that celecoxib produces secondary
effects because it affects the activity of several types of ion channels. Herein it
is reported that at therapeutically relevant concentrations celecoxib interacts
with Shab Kþ channels only inducing fast inactivation gating without blocking
the pore or significantly affecting other gating processes. This induced-
inactivation in turn causes a reduction of the size of IK. Also it was found
that a promoted fast inactivation that develops from both open and closed states
takes place when at least two celecoxib molecules bind to each channel. Our
results show for the first time that in addition to its intended therapeutic target
celecoxib is a unique tool to further study the mechanism of Shab channel
inactivation.
